| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | microvillus | 2.90e-06 | 123 | 105 | 7 | GO:0005902 | |
| GeneOntologyCellularComponent | Schwann cell microvillus | 7.47e-05 | 3 | 105 | 2 | GO:0097454 | |
| Domain | Calreticulin | 2.90e-05 | 2 | 101 | 2 | IPR009169 | |
| Domain | RPAP3-like_C | 8.66e-05 | 3 | 101 | 2 | IPR025986 | |
| Domain | RPAP3_C | 8.66e-05 | 3 | 101 | 2 | PF13877 | |
| Domain | - | 1.65e-04 | 95 | 101 | 5 | 2.60.120.200 | |
| Domain | ERM_C_dom | 1.73e-04 | 4 | 101 | 2 | IPR011259 | |
| Domain | Neurofascin/L1/NrCAM_C | 1.73e-04 | 4 | 101 | 2 | IPR026966 | |
| Domain | Calret/calnex | 1.73e-04 | 4 | 101 | 2 | IPR001580 | |
| Domain | Bravo_FIGEY | 1.73e-04 | 4 | 101 | 2 | PF13882 | |
| Domain | CALRETICULIN_1 | 1.73e-04 | 4 | 101 | 2 | PS00803 | |
| Domain | CALRETICULIN_2 | 1.73e-04 | 4 | 101 | 2 | PS00804 | |
| Domain | Calret/calnex_CS | 1.73e-04 | 4 | 101 | 2 | IPR018124 | |
| Domain | ERM | 1.73e-04 | 4 | 101 | 2 | PF00769 | |
| Domain | Calreticulin | 1.73e-04 | 4 | 101 | 2 | PF00262 | |
| Domain | ERM | 1.73e-04 | 4 | 101 | 2 | IPR011174 | |
| Domain | ConA-like_dom | 1.87e-04 | 219 | 101 | 7 | IPR013320 | |
| Domain | - | 2.70e-04 | 391 | 101 | 9 | 2.30.29.30 | |
| Domain | Cyt_P450_CYP7A1-type | 2.86e-04 | 5 | 101 | 2 | IPR024204 | |
| Domain | Calreticulin/calnexin_P_dom | 2.86e-04 | 5 | 101 | 2 | IPR009033 | |
| Domain | ENTH | 4.28e-04 | 6 | 101 | 2 | PF01417 | |
| Domain | PH_dom-like | 5.03e-04 | 426 | 101 | 9 | IPR011993 | |
| Domain | Moesin_tail | 5.97e-04 | 7 | 101 | 2 | IPR008954 | |
| Domain | - | 9.12e-04 | 207 | 101 | 6 | 1.25.40.10 | |
| Domain | ENTH | 1.02e-03 | 9 | 101 | 2 | PS50942 | |
| Domain | ENTH | 1.02e-03 | 9 | 101 | 2 | SM00273 | |
| Domain | AAA | 1.11e-03 | 144 | 101 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.11e-03 | 144 | 101 | 5 | IPR003593 | |
| Domain | ENTH | 1.27e-03 | 10 | 101 | 2 | IPR013809 | |
| Domain | Cyt_P450_E_grp-IV | 1.27e-03 | 10 | 101 | 2 | IPR002403 | |
| Domain | PH | 1.53e-03 | 229 | 101 | 6 | PF00169 | |
| Domain | Elongated_TPR_rpt_dom | 1.54e-03 | 11 | 101 | 2 | IPR023114 | |
| Domain | TPR-like_helical_dom | 1.67e-03 | 233 | 101 | 6 | IPR011990 | |
| Domain | ER_TARGET | 2.09e-03 | 47 | 101 | 3 | PS00014 | |
| Domain | TPR_8 | 2.96e-03 | 53 | 101 | 3 | PF13181 | |
| Domain | CADHERIN_1 | 3.31e-03 | 113 | 101 | 4 | PS00232 | |
| Domain | Cadherin | 3.31e-03 | 113 | 101 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 3.41e-03 | 114 | 101 | 4 | PS50268 | |
| Domain | - | 3.41e-03 | 114 | 101 | 4 | 2.60.40.60 | |
| Domain | CA | 3.52e-03 | 115 | 101 | 4 | SM00112 | |
| Domain | Cadherin-like | 3.63e-03 | 116 | 101 | 4 | IPR015919 | |
| Domain | Cadherin | 3.86e-03 | 118 | 101 | 4 | IPR002126 | |
| Domain | PH | 4.01e-03 | 278 | 101 | 6 | SM00233 | |
| Domain | PH_DOMAIN | 4.08e-03 | 279 | 101 | 6 | PS50003 | |
| Domain | PH_domain | 4.16e-03 | 280 | 101 | 6 | IPR001849 | |
| Domain | Zinc_finger_PHD-type_CS | 5.26e-03 | 65 | 101 | 3 | IPR019786 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | EPRS1 NUP50 HBS1L RNMT KRR1 DIS3 DDX1 LRPPRC XRN1 PAN2 PPIE EBNA1BP2 PRORP SNRNP200 | 5.80e-05 | 724 | 81 | 14 | M16843 |
| Pubmed | DNAJB12 EHBP1 EZR EPRS1 HBS1L RPAP3 BCLAF1 DNAJC7 STAU1 MSN JPH1 LRPPRC ABCE1 NUFIP2 XRN1 SMCR8 PCDH7 SNRNP200 | 4.48e-12 | 708 | 105 | 18 | 39231216 | |
| Pubmed | DNAJB12 EZR EPRS1 HBS1L MYO1C DOCK8 CALR BAG5 AGPAT3 MCM7 KRR1 DNAJC7 DIS3 DDX1 STAU1 LRPPRC ABCE1 CHD5 NUFIP2 XRN1 SLC27A4 | 4.10e-11 | 1168 | 105 | 21 | 19946888 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EHBP1 EPRS1 NUP50 SIN3B SLK RPAP3 CDK12 BCLAF1 ECD LASP1 DIS3 STAU1 ABCE1 NUFIP2 XRN1 EBNA1BP2 SMCR8 SNRNP200 TOP2B | 4.94e-11 | 934 | 105 | 19 | 33916271 |
| Pubmed | EZR EPRS1 MYO1C RPAP3 CALR BCLAF1 BAG5 MCM7 DDX1 MSN LRPPRC HPD SEPTIN11 EBNA1BP2 SNRNP200 | 8.89e-11 | 538 | 105 | 15 | 28524877 | |
| Pubmed | EZR EPRS1 SPAG1 MYO1C BCLAF1 ECD DNAJC7 DDX1 ABCB1 MSN LRPPRC PHF20L1 FAM186A CHD5 XRN1 MYOM2 EBNA1BP2 MCF2L CDH1 SKAP2 TOP2B SLC27A4 | 2.98e-10 | 1442 | 105 | 22 | 35575683 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 HBS1L MYO1C RPAP3 OAS3 MCM7 LASP1 KRR1 DIS3 DDX1 ASAP1 STAU1 MSN S100A7 LRPPRC ABCE1 XRN1 EBNA1BP2 SNRNP200 TOP2B SLC27A4 | 5.94e-10 | 1353 | 105 | 21 | 29467282 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EZR NUP50 SIN3B SPAG1 SLK RNMT MYO1C BCLAF1 OAS3 MCM7 LASP1 DNAJC7 DIS3 ASAP1 STAU1 MSN LRPPRC ABCE1 SEPTIN11 MMUT SLC27A4 | 7.14e-10 | 1367 | 105 | 21 | 32687490 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DNAJB12 EZR EPRS1 HBS1L SLK RPAP3 ECD BAG5 MCM7 RDH13 LASP1 KRR1 DNAJC7 DIS3 DDX1 MSN LRPPRC PPIE EBNA1BP2 SNRNP200 TOP2B | 1.32e-09 | 1415 | 105 | 21 | 28515276 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EZR EPRS1 NUP50 HBS1L SLK MYO1C CALR BCLAF1 ZNF329 MCM7 KRR1 DNAJC7 DIS3 DDX1 STAU1 LRPPRC ABCE1 EBNA1BP2 SNRNP200 TOP2B SLC27A4 | 1.50e-09 | 1425 | 105 | 21 | 30948266 |
| Pubmed | DNAJB12 MYO1C CALR BCLAF1 ECD BAG5 OAS3 MCM7 RDH13 KRR1 DNAJC7 DIS3 DDX1 STAU1 LRPPRC ING4 EBNA1BP2 EPN1 SNRNP200 TOP2B SLC27A4 | 1.80e-09 | 1440 | 105 | 21 | 30833792 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EZR EPRS1 MYO1C CALR BCLAF1 ECD DNAJC7 DIS3 MSN S100A7 LRPPRC NUFIP2 SNRNP200 | 2.29e-09 | 477 | 105 | 13 | 31300519 |
| Pubmed | DNAJB12 EPRS1 MYO1C BCLAF1 BAG5 MCM7 LASP1 DNAJC7 DIS3 DDX1 STAU1 LRPPRC ABCE1 NUFIP2 XRN1 SEPTIN11 PPIE EBNA1BP2 CDH1 | 5.92e-09 | 1247 | 105 | 19 | 27684187 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EZR EPRS1 MYO1C RPAP3 BCLAF1 ECD OAS3 MCM7 KRR1 DDX1 STAU1 MSN LRPPRC CHD5 NUFIP2 PPIE EBNA1BP2 CDH1 SNRNP200 | 6.73e-09 | 1257 | 105 | 19 | 36526897 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RNMT MYO1C BCLAF1 MCM7 LASP1 KRR1 DNAJC7 DIS3 DDX1 STAU1 S100A7 LRPPRC NUFIP2 EBNA1BP2 SNRNP200 TOP2B SLC27A4 | 7.12e-09 | 989 | 105 | 17 | 36424410 |
| Pubmed | EPRS1 HBS1L SLK RPAP3 CDK12 CLSTN1 DIS3 DDX1 MSN SMYD4 ABCE1 XRN1 EPN1 SLC27A4 | 1.06e-08 | 650 | 105 | 14 | 38777146 | |
| Pubmed | EZR EPRS1 SIN3B HBS1L SLK RPAP3 CDK12 BCLAF1 MCM7 DNAJC7 NUFIP2 XRN1 SNRNP200 | 1.22e-08 | 549 | 105 | 13 | 38280479 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 22177047 | ||
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | HBS1L BCLAF1 MCM7 DNAJC7 DDX1 STAU1 LRPPRC ABCE1 EBNA1BP2 PRORP SNRNP200 SLC27A4 | 2.92e-08 | 486 | 105 | 12 | 30940648 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | EZR EPRS1 BCLAF1 MCM7 KRR1 DIS3 DDX1 STAU1 MSN NUFIP2 PPIE EBNA1BP2 SNRNP200 TOP2B | 3.42e-08 | 714 | 105 | 14 | 28302793 |
| Pubmed | 6.17e-08 | 327 | 105 | 10 | 31409639 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 8.72e-08 | 182 | 105 | 8 | 32239614 | |
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 8.95e-08 | 256 | 105 | 9 | 33397691 | |
| Pubmed | HBS1L SLK RPAP3 CALR CDK12 MCM7 LASP1 KRR1 DIS3 DDX1 STAU1 ABCE1 EBNA1BP2 | 9.20e-08 | 653 | 105 | 13 | 33742100 | |
| Pubmed | DNAJB12 POGLUT3 RPAP3 CALR BCLAF1 ECD BAG5 DNAJC7 STAU1 JPH1 LRPPRC ANKRD11 COL14A1 PPIE EBNA1BP2 SMCR8 PCDH7 SNRNP200 TOP2B | 9.59e-08 | 1487 | 105 | 19 | 33957083 | |
| Pubmed | Functional binding interaction identified between the axonal CAM L1 and members of the ERM family. | 1.07e-07 | 4 | 105 | 3 | 12070130 | |
| Pubmed | EPRS1 RNMT MYO1C BCLAF1 KRR1 DNAJC7 DIS3 DDX1 STAU1 LRPPRC NUFIP2 SNRNP200 | 1.14e-07 | 551 | 105 | 12 | 34728620 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | EZR NUP50 HBS1L CDK12 BCLAF1 ZFP14 MCM7 KRR1 STAU1 MSN EBNA1BP2 SNRNP200 JHY | 1.88e-07 | 695 | 105 | 13 | 23602568 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | EPRS1 BCLAF1 MCM7 KRR1 DDX1 STAU1 S100A7 CHD5 NUFIP2 EBNA1BP2 SNRNP200 TOP2B | 3.09e-07 | 605 | 105 | 12 | 28977666 |
| Pubmed | PPARγ Interaction with UBR5/ATMIN Promotes DNA Repair to Maintain Endothelial Homeostasis. | 3.32e-07 | 90 | 105 | 6 | 30699358 | |
| Pubmed | EZR PEG3 ASAP1 MSN JPH1 CLIP4 LRPPRC APPL2 COL14A1 MYOM2 SKAP2 | 3.38e-07 | 497 | 105 | 11 | 23414517 | |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | EZR HBS1L RNMT MYO1C CDK12 LASP1 DIS3 MSN APPL2 XRN1 SEPTIN11 | 3.45e-07 | 498 | 105 | 11 | 36634849 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EZR EPRS1 NUP50 HBS1L SLK CALR BAG5 MCM7 DNAJC7 DIS3 CDC37L1 DDX1 MSN APPL2 ABCE1 SEPTIN11 EPN1 SNRNP200 | 3.51e-07 | 1455 | 105 | 18 | 22863883 |
| Pubmed | EZR EPRS1 NUP50 MYO1C CALR CDK12 BCLAF1 DDX1 SEPTIN11 PPIE SNRNP200 | 4.04e-07 | 506 | 105 | 11 | 30890647 | |
| Pubmed | 5.50e-07 | 22 | 105 | 4 | 34799561 | ||
| Pubmed | LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex. | 5.50e-07 | 22 | 105 | 4 | 25982273 | |
| Pubmed | EPRS1 BCLAF1 MCM7 DIS3 DDX1 STAU1 S100A7 LRPPRC NUFIP2 EBNA1BP2 SNRNP200 TOP2B | 5.69e-07 | 641 | 105 | 12 | 36057605 | |
| Pubmed | EPRS1 MYO1C CALR DDX1 STAU1 MSN S100A7 LRPPRC NUFIP2 SLC27A4 | 5.90e-07 | 418 | 105 | 10 | 35338135 | |
| Pubmed | EPRS1 NUP50 RPAP3 CALR MCM7 DNAJC7 DIS3 LRPPRC ABCE1 XRN1 MMUT | 6.85e-07 | 534 | 105 | 11 | 35032548 | |
| Pubmed | MYO1C CALR KRR1 DIS3 STAU1 MSN LRPPRC ABCE1 NUFIP2 XRN1 EBNA1BP2 SNRNP200 | 6.91e-07 | 653 | 105 | 12 | 22586326 | |
| Pubmed | 7.40e-07 | 241 | 105 | 8 | 23125841 | ||
| Pubmed | Identification of proximal SUMO-dependent interactors using SUMO-ID. | 1.02e-06 | 444 | 105 | 10 | 34795231 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EZR EPRS1 MYO1C CALR BCLAF1 MCM7 DDX1 MSN JPH1 LRPPRC CHD5 NUFIP2 EBNA1BP2 SNRNP200 | 1.06e-06 | 949 | 105 | 14 | 36574265 |
| Pubmed | EZR EPRS1 NUP50 SIN3B DOCK8 BCLAF1 MCM7 LASP1 DDX1 STAU1 MSN LIMD2 ABCE1 SNRNP200 TOP2B | 1.16e-06 | 1103 | 105 | 15 | 34189442 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EZR EPRS1 SLK CALR CDK12 BAG5 MCM7 DNAJC7 DDX1 STAU1 MSN LRPPRC NUFIP2 SEPTIN11 SNRNP200 | 1.92e-06 | 1149 | 105 | 15 | 35446349 |
| Pubmed | EZR EPRS1 CALR MCM7 DNAJC7 DIS3 DDX1 STAU1 LRPPRC NUFIP2 SNRNP200 SLC27A4 | 2.05e-06 | 725 | 105 | 12 | 27025967 | |
| Pubmed | Radixin regulates cell migration and cell-cell adhesion through Rac1. | 2.22e-06 | 9 | 105 | 3 | 22467863 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | EHBP1 EZR NUP50 SPAG1 RPAP3 CALR AGPAT3 MCM7 DIS3 DDX1 LRPPRC NUFIP2 PAN2 SEPTIN11 COL14A1 SNRNP200 | 2.23e-06 | 1321 | 105 | 16 | 27173435 |
| Pubmed | EPRS1 NUP50 HBS1L RNMT RPAP3 BAG5 PEG3 MCM7 KRR1 DNAJC7 DDX1 STAU1 LRPPRC PPIE EBNA1BP2 SNRNP200 | 2.55e-06 | 1335 | 105 | 16 | 29229926 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EZR EPRS1 CALR BCLAF1 MCM7 LASP1 DNAJC7 DDX1 ABCB1 STAU1 LRPPRC EBNA1BP2 SNRNP200 TOP2B | 2.57e-06 | 1024 | 105 | 14 | 24711643 |
| Pubmed | DNAJB12 EPRS1 BAG5 MCM7 DNAJC7 DIS3 DDX1 STAU1 LRPPRC SNRNP200 TOP2B | 3.81e-06 | 638 | 105 | 11 | 33239621 | |
| Pubmed | EZR NUP50 DOCK8 CALR MCM7 ASAP1 MSN JPH1 S100A7 PPIE VAV3 EBNA1BP2 MCF2L | 4.04e-06 | 916 | 105 | 13 | 32203420 | |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | DNAJB12 EZR EPRS1 MYO1C CALR MCM7 STAU1 MSN LRPPRC EBNA1BP2 CDH1 | 4.35e-06 | 647 | 105 | 11 | 26618866 |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 5.11e-06 | 221 | 105 | 7 | 29991511 | |
| Pubmed | Alpha6beta4 integrin and dystroglycan cooperate to stabilize the myelin sheath. | 5.77e-06 | 12 | 105 | 3 | 18579745 | |
| Pubmed | EPRS1 SLK MYO1C DOCK8 BCLAF1 L1CAM NFASC DDX1 ASAP1 STAU1 LRPPRC APPL2 NUFIP2 XRN1 SEPTIN11 SNRNP200 | 6.15e-06 | 1431 | 105 | 16 | 37142655 | |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | DNAJB12 EPRS1 POGLUT3 MYO1C CALR AGPAT3 OAS3 MCM7 ADAMTS5 CLSTN1 DIS3 DDX1 MSN LRPPRC SNRNP200 SLC27A4 | 7.31e-06 | 1451 | 105 | 16 | 30550785 |
| Pubmed | DNAJB12 EPRS1 CDK12 MCM7 KRR1 DNAJC7 ABCB1 STAU1 LRPPRC NUFIP2 PPIE EBNA1BP2 SNRNP200 | 7.55e-06 | 971 | 105 | 13 | 33306668 | |
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 7.57e-06 | 330 | 105 | 8 | 33301849 | |
| Pubmed | 7.57e-06 | 330 | 105 | 8 | 32529326 | ||
| Pubmed | 8.09e-06 | 333 | 105 | 8 | 36779763 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25299115 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 29587669 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 28939985 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 12111362 | ||
| Pubmed | Protocadherin 7 inhibits cell migration and invasion through E-cadherin in gastric cancer. | 9.03e-06 | 2 | 105 | 2 | 28381163 | |
| Pubmed | Expression of ezrin and moesin in primary breast carcinoma and matched lymph node metastases. | 9.03e-06 | 2 | 105 | 2 | 28624994 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 30551188 | ||
| Pubmed | Immunohistochemical assessment of ezrin and moesin in colorectal carcinoma. | 9.03e-06 | 2 | 105 | 2 | 27042764 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 21590275 | ||
| Pubmed | Moesin: a member of the protein 4.1-talin-ezrin family of proteins. | 9.03e-06 | 2 | 105 | 2 | 1924289 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25089713 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 20156840 | ||
| Pubmed | LRPPRC contributes to the cisplatin resistance of lung cancer cells by regulating MDR1 expression. | 9.03e-06 | 2 | 105 | 2 | 33649818 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 9213396 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 7579708 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 23214316 | ||
| Pubmed | Ezrin has properties to self-associate at the plasma membrane. | 9.03e-06 | 2 | 105 | 2 | 7844168 | |
| Pubmed | Expression and clinical significance of Ezrin and E-cadherin in esophageal squamous cell carcinoma. | 9.03e-06 | 2 | 105 | 2 | 20193117 | |
| Pubmed | Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer. | 9.03e-06 | 2 | 105 | 2 | 18459457 | |
| Pubmed | Identification of a novel calreticulin isoform (Crt2) in human and mouse. | 9.03e-06 | 2 | 105 | 2 | 12384296 | |
| Pubmed | [Expression of Ezrin and E-cadherin in nasopharyngeal carcinoma and its significance]. | 9.03e-06 | 2 | 105 | 2 | 20871163 | |
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 25955302 | ||
| Pubmed | 9.03e-06 | 2 | 105 | 2 | 8248180 | ||
| Pubmed | Precise Somatotopic Thalamocortical Axon Guidance Depends on LPA-Mediated PRG-2/Radixin Signaling. | 9.50e-06 | 14 | 105 | 3 | 27641493 | |
| Pubmed | EZR RNMT MYO1C CALR MCM7 DNAJC7 DDX1 STAU1 MSN LRPPRC ABCE1 SNRNP200 | 9.56e-06 | 844 | 105 | 12 | 25963833 | |
| Pubmed | 9.70e-06 | 44 | 105 | 4 | 26471122 | ||
| Pubmed | 9.74e-06 | 244 | 105 | 7 | 28902428 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EZR EPRS1 SLK MYO1C BCLAF1 ECD MCM7 DNAJC7 DDX1 MSN SEPTIN11 SNRNP200 | 9.90e-06 | 847 | 105 | 12 | 35235311 |
| Pubmed | Mapping Extracellular Protein-Protein Interactions Using Extracellular Proximity Labeling (ePL). | 1.05e-05 | 247 | 105 | 7 | 39238192 | |
| Pubmed | DNAJB12 NUP50 RNMT CDK12 BCLAF1 MCM7 LASP1 DNAJC7 DIS3 DDX1 MSN ABCE1 TOP2B | 1.20e-05 | 1014 | 105 | 13 | 32416067 | |
| Pubmed | 1.31e-05 | 469 | 105 | 9 | 37314180 | ||
| Pubmed | Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin. | 1.35e-05 | 170 | 105 | 6 | 16159877 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 1.45e-05 | 361 | 105 | 8 | 30344098 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DNAJB12 CALR CDK12 BCLAF1 ZNF329 L1CAM NFASC MCM7 CENPI NUFIP2 EBNA1BP2 SNRNP200 TOP2B SLC27A4 | 1.59e-05 | 1203 | 105 | 14 | 29180619 |
| Pubmed | 1.76e-05 | 17 | 105 | 3 | 20706633 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 1.78e-05 | 268 | 105 | 7 | 33024031 | |
| Pubmed | 1.88e-05 | 491 | 105 | 9 | 22623428 | ||
| Pubmed | 2.07e-05 | 109 | 105 | 5 | 29511296 | ||
| Pubmed | TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation. | 2.07e-05 | 109 | 105 | 5 | 33554859 | |
| Pubmed | VANGL2 regulates luminal epithelial organization and cell turnover in the mammary gland. | 2.11e-05 | 18 | 105 | 3 | 31068622 | |
| Interaction | KCNA3 interactions | DNAJB12 EHBP1 EZR EPRS1 HBS1L MYO1C RPAP3 BCLAF1 DNAJC7 STAU1 MSN JPH1 LRPPRC ABCE1 NUFIP2 XRN1 SMCR8 PCDH7 SNRNP200 | 9.19e-08 | 871 | 104 | 19 | int:KCNA3 |
| Interaction | PINK1 interactions | EZR EPRS1 MYO1C CALR BCLAF1 ECD BAG5 DNAJC7 DIS3 MSN S100A7 LRPPRC APPL2 NUFIP2 HEPHL1 SNRNP200 | 3.90e-07 | 679 | 104 | 16 | int:PINK1 |
| Interaction | NAA40 interactions | EHBP1 EPRS1 NUP50 SIN3B SLK RPAP3 CDK12 BCLAF1 ECD LASP1 DIS3 STAU1 ABCE1 NUFIP2 XRN1 EBNA1BP2 SMCR8 SNRNP200 TOP2B | 5.45e-07 | 978 | 104 | 19 | int:NAA40 |
| Interaction | KDF1 interactions | 6.76e-07 | 192 | 104 | 9 | int:KDF1 | |
| Interaction | CALD1 interactions | 1.15e-06 | 265 | 104 | 10 | int:CALD1 | |
| Interaction | RDX interactions | 2.14e-06 | 284 | 104 | 10 | int:RDX | |
| Interaction | EFTUD2 interactions | DNAJB12 EZR EPRS1 HBS1L SLK RPAP3 ECD BAG5 MCM7 RDH13 LASP1 KRR1 DIS3 DDX1 STAU1 MSN LRPPRC PAN2 PPIE EBNA1BP2 SNRNP200 TOP2B | 3.80e-06 | 1449 | 104 | 22 | int:EFTUD2 |
| Interaction | FGFR4 interactions | EHBP1 EZR LASP1 DNAJC7 ASAP1 MSN JPH1 APPL2 XRN1 SEPTIN11 SMCR8 PCDH7 | 4.29e-06 | 458 | 104 | 12 | int:FGFR4 |
| Interaction | SLK interactions | 4.86e-06 | 183 | 104 | 8 | int:SLK | |
| Interaction | FBXO25 interactions | 8.67e-06 | 198 | 104 | 8 | int:FBXO25 | |
| Interaction | PHLPP1 interactions | 8.76e-06 | 333 | 104 | 10 | int:PHLPP1 | |
| Interaction | PLEC interactions | 1.38e-05 | 430 | 104 | 11 | int:PLEC | |
| Interaction | STIP1 interactions | DNAJB12 EZR EPRS1 RPAP3 DOCK8 BAG5 MCM7 DNAJC7 DIS3 CDC37L1 DDX1 STAU1 MSN LRPPRC PCDH7 SNRNP200 TOP2B | 1.47e-05 | 1006 | 104 | 17 | int:STIP1 |
| Interaction | C16orf96 interactions | 1.56e-05 | 10 | 104 | 3 | int:C16orf96 | |
| Interaction | BRD7 interactions | NUP50 HBS1L BCLAF1 MCM7 DNAJC7 DDX1 STAU1 LRPPRC ABCE1 EBNA1BP2 PRORP SNRNP200 SLC27A4 | 2.43e-05 | 637 | 104 | 13 | int:BRD7 |
| Interaction | HSPE1 interactions | 2.82e-05 | 304 | 104 | 9 | int:HSPE1 | |
| Interaction | GSPT1 interactions | 2.97e-05 | 306 | 104 | 9 | int:GSPT1 | |
| Interaction | EXOSC2 interactions | 4.13e-05 | 180 | 104 | 7 | int:EXOSC2 | |
| Interaction | NSUN2 interactions | 4.52e-05 | 323 | 104 | 9 | int:NSUN2 | |
| Interaction | MAP4 interactions | 4.63e-05 | 324 | 104 | 9 | int:MAP4 | |
| Interaction | TRIOBP interactions | 5.10e-05 | 127 | 104 | 6 | int:TRIOBP | |
| Interaction | LOXL2 interactions | 5.18e-05 | 410 | 104 | 10 | int:LOXL2 | |
| Interaction | ACTC1 interactions | EZR EPRS1 NUP50 MYO1C CALR CDK12 BCLAF1 LASP1 DDX1 PAN2 SEPTIN11 PPIE SNRNP200 | 5.87e-05 | 694 | 104 | 13 | int:ACTC1 |
| Interaction | IFITM3 interactions | EHBP1 MYO1C CALR BAG5 AGPAT3 MSN APPL2 ABCE1 EPN1 SMCR8 PCDH7 | 6.90e-05 | 513 | 104 | 11 | int:IFITM3 |
| Interaction | MEX3C interactions | 7.42e-05 | 84 | 104 | 5 | int:MEX3C | |
| Interaction | UACA interactions | 7.46e-05 | 136 | 104 | 6 | int:UACA | |
| Interaction | SNCA interactions | EZR HBS1L RNMT MYO1C CDK12 BAG5 LASP1 DIS3 MSN APPL2 XRN1 SEPTIN11 SNRNP200 | 8.05e-05 | 716 | 104 | 13 | int:SNCA |
| Interaction | EPHA10 interactions | 8.30e-05 | 86 | 104 | 5 | int:EPHA10 | |
| Interaction | PTGES3 interactions | HBS1L RPAP3 CALR ECD MCM7 DNAJC7 LRPPRC ABCE1 SNRNP200 TOP2B | 8.80e-05 | 437 | 104 | 10 | int:PTGES3 |
| Interaction | CHD4 interactions | EPRS1 SLK BCLAF1 KRR1 DDX1 STAU1 S100A7 PHF20L1 CHD5 NUFIP2 XRN1 EBNA1BP2 CDH1 SNRNP200 TOP2B | 9.21e-05 | 938 | 104 | 15 | int:CHD4 |
| Interaction | FGFR1 interactions | EHBP1 EZR L1CAM TSHR ASAP1 MSN NUFIP2 SEPTIN11 EPN1 SMCR8 CDH1 PCDH7 | 1.01e-04 | 632 | 104 | 12 | int:FGFR1 |
| Interaction | RIPK4 interactions | DNAJB12 RPAP3 CALR BCLAF1 ECD BAG5 DNAJC7 JPH1 ABCE1 SLC27A4 | 1.04e-04 | 446 | 104 | 10 | int:RIPK4 |
| Interaction | CTSS interactions | 1.06e-04 | 145 | 104 | 6 | int:CTSS | |
| Interaction | LRRC59 interactions | DNAJB12 EHBP1 POGLUT3 DOCK8 CALR BAG5 STAU1 JPH1 LRPPRC NUFIP2 COL14A1 SMCR8 CDH1 SNRNP200 | 1.11e-04 | 845 | 104 | 14 | int:LRRC59 |
| Interaction | SIRT7 interactions | MYO1C CALR MCM7 KRR1 DIS3 STAU1 MSN LRPPRC ABCE1 NUFIP2 XRN1 EBNA1BP2 SNRNP200 | 1.18e-04 | 744 | 104 | 13 | int:SIRT7 |
| Interaction | CD274 interactions | 1.25e-04 | 369 | 104 | 9 | int:CD274 | |
| Interaction | CEBPB interactions | EZR EPRS1 NUP50 HBS1L CALR BCLAF1 MCM7 LASP1 DNAJC7 DIS3 DDX1 STAU1 MSN S100A7 LRPPRC ABCE1 NUFIP2 XRN1 SNRNP200 | 1.33e-04 | 1443 | 104 | 19 | int:CEBPB |
| Interaction | EZR interactions | 1.34e-04 | 553 | 104 | 11 | int:EZR | |
| Interaction | H1-4 interactions | EPRS1 NUP50 KRR1 DNAJC7 ASAP1 STAU1 SMYD4 XRN1 PAN2 EBNA1BP2 CDH1 TOP2B | 1.44e-04 | 656 | 104 | 12 | int:H1-4 |
| Interaction | WDR1 interactions | 1.46e-04 | 220 | 104 | 7 | int:WDR1 | |
| Interaction | BIRC3 interactions | EZR EPRS1 NUP50 MYO1C CALR BCLAF1 ZNF329 MCM7 KRR1 DNAJC7 DIS3 DDX1 STAU1 LRPPRC ABCE1 EBNA1BP2 SNRNP200 TOP2B | 1.52e-04 | 1334 | 104 | 18 | int:BIRC3 |
| Interaction | RPL4 interactions | CDK12 BAG5 KRR1 STAU1 ABCE1 NUFIP2 XRN1 ANKRD11 PAN2 PPIE EBNA1BP2 MCF2L SNRNP200 | 1.54e-04 | 764 | 104 | 13 | int:RPL4 |
| Interaction | ACE2 interactions | EPRS1 RNMT MYO1C BCLAF1 MCM7 LASP1 DIS3 DDX1 STAU1 S100A7 LRPPRC APPL2 NUFIP2 EBNA1BP2 SNRNP200 TOP2B | 1.69e-04 | 1106 | 104 | 16 | int:ACE2 |
| Interaction | SEPTIN7 interactions | 1.81e-04 | 228 | 104 | 7 | int:SEPTIN7 | |
| Interaction | MIR7-1 interactions | 1.95e-04 | 103 | 104 | 5 | int:MIR7-1 | |
| Interaction | POLR1B interactions | 1.95e-04 | 162 | 104 | 6 | int:POLR1B | |
| Interaction | ATXN2 interactions | 2.15e-04 | 312 | 104 | 8 | int:ATXN2 | |
| Interaction | MYO6 interactions | 2.20e-04 | 398 | 104 | 9 | int:MYO6 | |
| Interaction | PLS3 interactions | 2.30e-04 | 237 | 104 | 7 | int:PLS3 | |
| Interaction | NCL interactions | EPRS1 RPAP3 BAG5 LASP1 STAU1 JPH1 PAN2 ING4 PPIE EBNA1BP2 PCDH7 SNRNP200 TOP2B | 2.35e-04 | 798 | 104 | 13 | int:NCL |
| Interaction | ISG15 interactions | 2.38e-04 | 494 | 104 | 10 | int:ISG15 | |
| Interaction | CD44 interactions | 2.42e-04 | 239 | 104 | 7 | int:CD44 | |
| Interaction | KIF23 interactions | EPRS1 RNMT MYO1C BCLAF1 KRR1 DDX1 STAU1 LRPPRC TTLL6 CENPI NUFIP2 EBNA1BP2 SNRNP200 TOP2B PADI1 | 2.59e-04 | 1031 | 104 | 15 | int:KIF23 |
| Interaction | CTSB interactions | 2.61e-04 | 242 | 104 | 7 | int:CTSB | |
| Interaction | KANSL1L interactions | 2.61e-04 | 5 | 104 | 2 | int:KANSL1L | |
| Interaction | STK10 interactions | 2.61e-04 | 60 | 104 | 4 | int:STK10 | |
| Interaction | HNRNPU interactions | EPRS1 NUP50 CALR BCLAF1 BAG5 MCM7 KRR1 DDX1 STAU1 LRPPRC PAN2 PPIE EBNA1BP2 PCDH7 SNRNP200 | 2.70e-04 | 1035 | 104 | 15 | int:HNRNPU |
| Interaction | EP300 interactions | HBS1L SLK RPAP3 CALR CDK12 MCM7 LASP1 KRR1 DIS3 DDX1 STAU1 ABCE1 SEPTIN11 ING4 EBNA1BP2 CDH1 SNRNP200 TOP2B | 2.78e-04 | 1401 | 104 | 18 | int:EP300 |
| Interaction | KIAA1143 interactions | 2.79e-04 | 61 | 104 | 4 | int:KIAA1143 | |
| Interaction | RBM39 interactions | EZR EPRS1 CDK12 BCLAF1 MCM7 KRR1 DIS3 DDX1 STAU1 MSN NUFIP2 PPIE EBNA1BP2 SNRNP200 TOP2B | 2.90e-04 | 1042 | 104 | 15 | int:RBM39 |
| Interaction | CAPZB interactions | DNAJB12 EPRS1 MYO1C RPAP3 BAG5 DDX1 STAU1 MSN LRPPRC ABCE1 NUFIP2 XRN1 PAN2 CDH1 TOP2B | 3.11e-04 | 1049 | 104 | 15 | int:CAPZB |
| Interaction | L1CAM interactions | 3.35e-04 | 64 | 104 | 4 | int:L1CAM | |
| Interaction | RAPH1 interactions | 3.35e-04 | 64 | 104 | 4 | int:RAPH1 | |
| Interaction | HNRNPA1 interactions | EPRS1 SLK CALR BCLAF1 TSHR DDX1 STAU1 MSN LRPPRC XRN1 PAN2 PPIE PCDH7 SNRNP200 | 3.52e-04 | 945 | 104 | 14 | int:HNRNPA1 |
| Interaction | ECD interactions | 3.52e-04 | 117 | 104 | 5 | int:ECD | |
| Interaction | GBA2 interactions | 3.57e-04 | 27 | 104 | 3 | int:GBA2 | |
| Interaction | RNF43 interactions | 3.68e-04 | 427 | 104 | 9 | int:RNF43 | |
| Interaction | ASNS interactions | 3.86e-04 | 184 | 104 | 6 | int:ASNS | |
| Interaction | CUL7 interactions | EZR EPRS1 CALR BCLAF1 MCM7 DNAJC7 DDX1 ABCB1 STAU1 LRPPRC EBNA1BP2 SNRNP200 TOP2B | 4.07e-04 | 845 | 104 | 13 | int:CUL7 |
| Interaction | EIF4G1 interactions | 4.07e-04 | 433 | 104 | 9 | int:EIF4G1 | |
| Interaction | RHOA interactions | EHBP1 EZR SLK DDX1 ADGRG6 MSN JPH1 ABCE1 PPIE VAV3 PRORP MCF2L SMCR8 CDH1 PCDH7 TOP2B | 4.17e-04 | 1199 | 104 | 16 | int:RHOA |
| Interaction | CIT interactions | EZR NUP50 HBS1L MYO1C RPAP3 CALR BCLAF1 OAS3 MCM7 DDX1 LIMD2 LRPPRC DNAH12 NUFIP2 MYOM2 EBNA1BP2 SNRNP200 TOP2B | 4.20e-04 | 1450 | 104 | 18 | int:CIT |
| Interaction | PPIB interactions | 4.21e-04 | 345 | 104 | 8 | int:PPIB | |
| Interaction | NPM1 interactions | EPRS1 NUP50 MYO1C CALR BCLAF1 KRR1 DDX1 STAU1 MSN CENPI NUFIP2 PAN2 EBNA1BP2 PCDH7 SNRNP200 TOP2B | 4.25e-04 | 1201 | 104 | 16 | int:NPM1 |
| Interaction | TBC1D10A interactions | 4.42e-04 | 29 | 104 | 3 | int:TBC1D10A | |
| Interaction | KIF5B interactions | 4.46e-04 | 348 | 104 | 8 | int:KIF5B | |
| Interaction | MAP1B interactions | DNAJB12 EPRS1 BAG5 MCM7 DDX1 STAU1 LRPPRC ABCE1 PAN2 SNRNP200 | 4.74e-04 | 539 | 104 | 10 | int:MAP1B |
| Interaction | YAP1 interactions | EZR EPRS1 SIN3B SLK MYO1C RPAP3 CDK12 BCLAF1 BAG5 MCM7 DNAJC7 DDX1 NUFIP2 CDH1 SNRNP200 | 4.89e-04 | 1095 | 104 | 15 | int:YAP1 |
| Interaction | B3GNT2 interactions | EPRS1 MYO1C CALR DDX1 STAU1 MSN S100A7 LRPPRC NUFIP2 SLC27A4 | 4.95e-04 | 542 | 104 | 10 | int:B3GNT2 |
| Interaction | HDAC2 interactions | SIN3B BAG5 MCM7 DDX1 MSN S100A7 PHF20L1 ABCE1 CHD5 NUFIP2 COL14A1 CDH1 TOP2B | 5.07e-04 | 865 | 104 | 13 | int:HDAC2 |
| Interaction | ERBB3 interactions | 5.08e-04 | 355 | 104 | 8 | int:ERBB3 | |
| Interaction | ZNF622 interactions | 5.13e-04 | 127 | 104 | 5 | int:ZNF622 | |
| Interaction | CHD3 interactions | EPRS1 SIN3B BCLAF1 MCM7 KRR1 DDX1 STAU1 PHF20L1 CHD5 EBNA1BP2 SNRNP200 TOP2B | 5.28e-04 | 757 | 104 | 12 | int:CHD3 |
| Interaction | CFTR interactions | DNAJB12 EZR EPRS1 POGLUT3 MYO1C CALR MCM7 RDH13 LASP1 CFHR5 DDX1 STAU1 MSN S100A7 LRPPRC SEPTIN11 EBNA1BP2 CDH1 | 5.36e-04 | 1480 | 104 | 18 | int:CFTR |
| Interaction | ZBTB2 interactions | 5.38e-04 | 450 | 104 | 9 | int:ZBTB2 | |
| Interaction | U2AF2 interactions | EZR EPRS1 CALR BCLAF1 LASP1 DNAJC7 STAU1 MSN LRPPRC PPIE SNRNP200 | 5.39e-04 | 651 | 104 | 11 | int:U2AF2 |
| Interaction | MIR18A interactions | 5.54e-04 | 73 | 104 | 4 | int:MIR18A | |
| Interaction | TMPO interactions | EPRS1 MYO1C BAG5 MCM7 DDX1 JPH1 LRPPRC ABCE1 EBNA1BP2 SMCR8 CDH1 SNRNP200 | 5.60e-04 | 762 | 104 | 12 | int:TMPO |
| Interaction | TRIM33 interactions | 5.64e-04 | 453 | 104 | 9 | int:TRIM33 | |
| Interaction | TIMP2 interactions | 5.87e-04 | 277 | 104 | 7 | int:TIMP2 | |
| Interaction | PSAP interactions | 6.00e-04 | 200 | 104 | 6 | int:PSAP | |
| Interaction | ISYNA1 interactions | 6.14e-04 | 75 | 104 | 4 | int:ISYNA1 | |
| Interaction | MIR7-3 interactions | 6.46e-04 | 76 | 104 | 4 | int:MIR7-3 | |
| Interaction | MIR429 interactions | 6.46e-04 | 76 | 104 | 4 | int:MIR429 | |
| Interaction | SRRM2 interactions | 6.49e-04 | 462 | 104 | 9 | int:SRRM2 | |
| Interaction | H1-2 interactions | EHBP1 EPRS1 NUP50 OAS3 KRR1 FAM186B STAU1 ABCE1 CENPI XRN1 EBNA1BP2 | 6.50e-04 | 666 | 104 | 11 | int:H1-2 |
| Interaction | BRCA1 interactions | DNAJB12 EZR EPRS1 RNMT RPAP3 PEG3 CUBN DDX1 STAU1 MSN CENPI NUFIP2 EBNA1BP2 CDH1 SNRNP200 TOP2B | 6.50e-04 | 1249 | 104 | 16 | int:BRCA1 |
| Interaction | LCMT2 interactions | 6.51e-04 | 33 | 104 | 3 | int:LCMT2 | |
| Interaction | DDR2 interactions | 7.00e-04 | 136 | 104 | 5 | int:DDR2 | |
| Interaction | MIR98 interactions | 7.12e-04 | 78 | 104 | 4 | int:MIR98 | |
| GeneFamily | Cytochrome P450 family 8 | 1.48e-05 | 2 | 70 | 2 | 1006 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.45e-04 | 206 | 70 | 6 | 682 | |
| GeneFamily | Cadherin related | 1.94e-03 | 17 | 70 | 2 | 24 | |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.94e-03 | 17 | 70 | 2 | 1291 | |
| GeneFamily | Fibronectin type III domain containing | 3.44e-03 | 160 | 70 | 4 | 555 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.52e-03 | 161 | 70 | 4 | 593 | |
| GeneFamily | PHD finger proteins | 5.13e-03 | 90 | 70 | 3 | 88 | |
| Coexpression | GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_DN | 1.18e-05 | 190 | 105 | 7 | M8457 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.59e-05 | 363 | 105 | 9 | M41103 | |
| Coexpression | GSE5589_WT_VS_IL6_KO_LPS_AND_IL6_STIM_MACROPHAGE_45MIN_DN | 1.59e-05 | 199 | 105 | 7 | M6646 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.05e-07 | 176 | 105 | 7 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 184 | 105 | 7 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 4.54e-07 | 198 | 105 | 7 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.86e-07 | 200 | 105 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 4.86e-07 | 200 | 105 | 7 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.48e-06 | 173 | 105 | 6 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | (2)_NK/T-(210)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 5.78e-06 | 189 | 105 | 6 | fa72e87e1e8cd7cbddae7b47e19cf90d181820a7 | |
| ToppCell | (2)_NK/T-(21)_NKT_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization) | 5.78e-06 | 189 | 105 | 6 | b37ad24898a14a4a3b2d6cea2637de2471f76e20 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-06 | 190 | 105 | 6 | 96a92212ea3fb35fa3d0da495e504edc61c71c23 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.14e-06 | 191 | 105 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-06 | 191 | 105 | 6 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.33e-06 | 192 | 105 | 6 | cd4c9b9ab17a779c154264f7459020f51e528ba5 | |
| ToppCell | Endothelial-endothelial_cell_of_vein|World / Lineage, Cell type, age group and donor | 6.72e-06 | 194 | 105 | 6 | 3cbd9622a68e89add90e589867d88c83c5a33476 | |
| ToppCell | Bronchus_Control_(B.)-Stromal-TX-Mesothelial-2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 7.77e-06 | 199 | 105 | 6 | 60a653100aff31f7f96796ff2ec634798bfb4b0d | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.99e-06 | 200 | 105 | 6 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Ntng1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.37e-06 | 56 | 105 | 4 | ad76712e6a99072f9c6dab6d746db54f754e14fd | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb-Inhibitory_Neuron.Gad1Gad2.Pvalb-Ntng1_(Entopeduncular_Nucleus_(Ent)_or_Zona_Incerta,_ventral_part_(ZIV)._State_signal?)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 9.37e-06 | 56 | 105 | 4 | 20a2977f41d3ecbc4fbee7ecd6dfb4b7ce0e4bb7 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-dnT|Bac-SEP / Disease, Lineage and Cell Type | 3.87e-05 | 160 | 105 | 5 | f5ca49801c981b903a85a64b21ece6b59fe91cbc | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_mature_unknown_2|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.23e-05 | 163 | 105 | 5 | e393e5ff885a42b2b44e430d3d5a58f5e50eb732 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.75e-05 | 167 | 105 | 5 | d7fe24cdc4b55a9555ce9e20699f5036b88148e9 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.88e-05 | 168 | 105 | 5 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.17e-05 | 170 | 105 | 5 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 5.31e-05 | 171 | 105 | 5 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.31e-05 | 171 | 105 | 5 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cel|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 172 | 105 | 5 | c0bda7153e02bee7d0326138cc684151c404c2a1 | |
| ToppCell | COVID-19-Heart-Neuronal|Heart / Disease (COVID-19 only), tissue and cell type | 5.61e-05 | 173 | 105 | 5 | 6fb5f9e6536a5d57fd8e6657b494047a2d0bc9c7 | |
| ToppCell | COVID-19_Mild-Neu_3|COVID-19_Mild / 5 Neutrophil clusters in COVID-19 patients | 6.09e-05 | 176 | 105 | 5 | 2049767fd591045cfcf5b1071d80798e52843f27 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.09e-05 | 176 | 105 | 5 | 269326c2bf44a9003d95bc6dbc839f08f25737ca | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-05 | 178 | 105 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 180 | 105 | 5 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_vein-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.77e-05 | 180 | 105 | 5 | 27e8bbee388e64dd79d70b160b76d45b1f398006 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.95e-05 | 181 | 105 | 5 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.32e-05 | 183 | 105 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.32e-05 | 183 | 105 | 5 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.71e-05 | 185 | 105 | 5 | c85bba1210f1d389add3e40be9b96abac40cf8c1 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.71e-05 | 185 | 105 | 5 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.11e-05 | 187 | 105 | 5 | fa01a61bfd13feb033ba1e35cf513707b1bff8c8 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1-6_LAMP5_CA13_(Lamp5_Lhx6_1)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.32e-05 | 188 | 105 | 5 | 3139540a656c0436b2123ea50741ff8d00112165 | |
| ToppCell | Fibroblast-C|World / shred on cell class and cell subclass (v4) | 8.53e-05 | 189 | 105 | 5 | 58e0400fbab5a0755504275aef5cf7986149abab | |
| ToppCell | facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-05 | 190 | 105 | 5 | 990ac07f4b0a22041daac7502f74fafd6d258cba | |
| ToppCell | facs-Thymus-Flowthrough-24m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-05 | 190 | 105 | 5 | fc9bbe5e6e0ec3cfa47bf479d8b09a0fc53169cc | |
| ToppCell | facs-Thymus-Flowthrough-24m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-05 | 190 | 105 | 5 | 39ecdf8815e235771132684dfc1aff1917e20965 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.74e-05 | 190 | 105 | 5 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | PND03-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-05 | 191 | 105 | 5 | fcdf3a747038e346a467eae8b7c293592658b53f | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-05 | 191 | 105 | 5 | 4b50fdd310701251e64e16cd2d07ce03dbfd3e3e | |
| ToppCell | Striatum-Macroglia-POLYDENDROCYTE|Striatum / BrainAtlas - Mouse McCarroll V32 | 8.96e-05 | 191 | 105 | 5 | 6bc9c7c86040f3ebce08c350e625e345581d4550 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.96e-05 | 191 | 105 | 5 | 75d2197076a9dfc868e8baf95bd4c5e44f438e3e | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.18e-05 | 192 | 105 | 5 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.18e-05 | 192 | 105 | 5 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.18e-05 | 192 | 105 | 5 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-05 | 193 | 105 | 5 | 32eb026d4317c1499d51294d396dfd5f293f9deb | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal_differentiating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 193 | 105 | 5 | 49f4fbec91acda4727703e0e359ed780eefb8a22 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-mature_enterocytic-Colonocyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-05 | 193 | 105 | 5 | 930df79b0600f43617052313294be33bcf5631f0 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 9.41e-05 | 193 | 105 | 5 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-05 | 193 | 105 | 5 | 25248b8e65d558b1a96a87c93e3e5b4c0ba168fe | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.41e-05 | 193 | 105 | 5 | f1f1097204e07a7bed416425b8256942038a734f | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 194 | 105 | 5 | ce32e60bcea1b8baf496ce9050832bc8c77d8434 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 194 | 105 | 5 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.64e-05 | 194 | 105 | 5 | a1dc157148885cc8d3685ac81a1f4e3562aeecc9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.87e-05 | 195 | 105 | 5 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.87e-05 | 195 | 105 | 5 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | E17.5-Mesenchymal|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.01e-04 | 196 | 105 | 5 | b4ee991445b612506372b9361ebfe72cb59b811e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 196 | 105 | 5 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.01e-04 | 196 | 105 | 5 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-04 | 196 | 105 | 5 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_immune_recruiting|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-04 | 197 | 105 | 5 | 31c8d6e565bbdc37843ce871fe91845b0cc18a9f | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.04e-04 | 197 | 105 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-04 | 198 | 105 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-B_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.06e-04 | 198 | 105 | 5 | 196257c4420ac801ed9fbb444f11718adb7560ae | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-04 | 198 | 105 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 1.06e-04 | 198 | 105 | 5 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.09e-04 | 199 | 105 | 5 | 53b6a661d381b1ed3ea96e61e8bd1750de7d9fda | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 1.09e-04 | 199 | 105 | 5 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.09e-04 | 199 | 105 | 5 | 9c753043024871b1f1436fc39defac4da85e10cd | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.09e-04 | 199 | 105 | 5 | d017dd91f9b10038f1f83753a766e534da2dbe89 | |
| ToppCell | lymphoid-T_cell-CD8+_Naive_T_cell|T_cell / Lineage, cell class and subclass | 1.09e-04 | 199 | 105 | 5 | 9ee40563e840a7fe97e7592539d42e19db438c64 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 200 | 105 | 5 | 84e145619a500530f42ed0fe72468ae95f4cbf1e | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 200 | 105 | 5 | cb00760ae75c30b1cb8526534aabd4ffc7c21000 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 200 | 105 | 5 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 1.11e-04 | 200 | 105 | 5 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.11e-04 | 200 | 105 | 5 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.1500015O10Rik_(1500015O10Rik)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 114 | 105 | 4 | c3feca81edee445cbe5e46a07e1a59327dc2e981 | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_2-Endothelial_Tip.Dcn.1500015O10Rik_(1500015O10Rik)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.53e-04 | 114 | 105 | 4 | 89350483d2ce57afc612fe25398e35af121d50f0 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.19e-04 | 125 | 105 | 4 | b162a5bfbb8ac5e65e13578fef9de442a9e4fd8b | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligodendroglioma-2|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.32e-04 | 127 | 105 | 4 | 018ffd9ff1913787cb0086a8581b399a121eaba1 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.19e-04 | 138 | 105 | 4 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.74e-04 | 144 | 105 | 4 | b622b605f7ec6083ec06c8ea0fd171e07c52f3de | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 4.26e-04 | 149 | 105 | 4 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.37e-04 | 150 | 105 | 4 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.37e-04 | 150 | 105 | 4 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.94e-04 | 155 | 105 | 4 | e1a20e88b9c0eaf7ca7004acc0eda096d1588563 | |
| ToppCell | 5'-Adult-Appendix-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.06e-04 | 156 | 105 | 4 | 58b9520fce6e259b36c3d59e82b712f5e7729e3e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-04 | 156 | 105 | 4 | a4b0e89255ea5d60198cb2b3e739981f9c9cf5c5 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 157 | 105 | 4 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.19e-04 | 157 | 105 | 4 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.57e-04 | 160 | 105 | 4 | 7064af50fc10e3ea03badf415306222b74db0f95 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 5.70e-04 | 161 | 105 | 4 | 64891f6f2ee1693c8481e951b9346e2f92d602e3 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-inner_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.70e-04 | 161 | 105 | 4 | 8d2987271da52fd8353557ac6faa4f7a4be0ed2a | |
| ToppCell | Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Synpr-Inhibitory_Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3_(Neuron.Gad1Gad2-Slc17a8.Synpr-Sncg-Yjefn3)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 5.79e-04 | 69 | 105 | 3 | 0862e6c8d8af4310b9a1f0879e51ee25115b26b1 | |
| Drug | AC1L8X8E | 2.03e-05 | 2 | 103 | 2 | CID000434318 | |
| Drug | AC1L8X8B | 2.03e-05 | 2 | 103 | 2 | CID000434317 | |
| Drug | AC1L9236 | 2.03e-05 | 2 | 103 | 2 | CID000411789 | |
| Drug | psorospermin | 2.03e-05 | 2 | 103 | 2 | CID000126451 | |
| Drug | moflomycin | 2.03e-05 | 2 | 103 | 2 | CID000163775 | |
| Drug | NSC348400 | 2.03e-05 | 2 | 103 | 2 | CID000335945 | |
| Drug | KW-2170 | 2.03e-05 | 2 | 103 | 2 | CID005747700 | |
| Drug | morpholinyldoxorubicin | 2.03e-05 | 2 | 103 | 2 | CID000092398 | |
| Disease | differentiated thyroid carcinoma | 6.49e-06 | 35 | 102 | 4 | EFO_1002017 | |
| Disease | neutrophil count | HBS1L POGLUT3 RNMT CEL MYO1C DOCK8 CYP8B1 BAG5 TSHR ADGRG6 FAM186A NUFIP2 ANKRD11 VAV3 PRORP | 8.02e-05 | 1382 | 102 | 15 | EFO_0004833 |
| Disease | hepatocellular carcinoma (is_marker_for) | 8.66e-05 | 301 | 102 | 7 | DOID:684 (is_marker_for) | |
| Disease | nasal type extranodal NK/T-cell lymphoma (is_marker_for) | 1.18e-04 | 5 | 102 | 2 | DOID:0080797 (is_marker_for) | |
| Disease | Colorectal Carcinoma | 1.62e-04 | 702 | 102 | 10 | C0009402 | |
| Disease | MASA syndrome (implicated_via_orthology) | 2.46e-04 | 7 | 102 | 2 | DOID:0060246 (implicated_via_orthology) | |
| Disease | Colorectal Neoplasms | 4.11e-04 | 277 | 102 | 6 | C0009404 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 4.23e-04 | 181 | 102 | 5 | DOID:684 (is_implicated_in) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 5.12e-04 | 45 | 102 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | Methylmalonic acidemia | 5.23e-04 | 10 | 102 | 2 | C0268583 | |
| Disease | Neuroblastoma | 5.82e-04 | 47 | 102 | 3 | C0027819 | |
| Disease | Prostatic Intraepithelial Neoplasias | 6.38e-04 | 11 | 102 | 2 | C0282612 | |
| Disease | Methylmalonic aciduria | 6.38e-04 | 11 | 102 | 2 | C1855119 | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 6.58e-04 | 49 | 102 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | Hematologic Neoplasms | 7.64e-04 | 12 | 102 | 2 | C0376545 | |
| Disease | papillary thyroid carcinoma | 7.64e-04 | 12 | 102 | 2 | EFO_0000641 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.25e-03 | 61 | 102 | 3 | DOID:3587 (is_marker_for) | |
| Disease | Prostatic Neoplasms | 1.36e-03 | 616 | 102 | 8 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.36e-03 | 616 | 102 | 8 | C0376358 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 1.37e-03 | 63 | 102 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | coagulation factor measurement | 2.16e-03 | 20 | 102 | 2 | EFO_0004634 | |
| Disease | Carcinomatosis | 2.51e-03 | 163 | 102 | 4 | C0205699 | |
| Disease | Carcinoma, Spindle-Cell | 2.51e-03 | 163 | 102 | 4 | C0205697 | |
| Disease | Undifferentiated carcinoma | 2.51e-03 | 163 | 102 | 4 | C0205698 | |
| Disease | Anaplastic carcinoma | 2.51e-03 | 163 | 102 | 4 | C0205696 | |
| Disease | Carcinoma | 2.56e-03 | 164 | 102 | 4 | C0007097 | |
| Disease | Drug-Induced Liver Disease | 2.83e-03 | 404 | 102 | 6 | C0860207 | |
| Disease | Drug-Induced Acute Liver Injury | 2.83e-03 | 404 | 102 | 6 | C3658290 | |
| Disease | Chemical and Drug Induced Liver Injury | 2.83e-03 | 404 | 102 | 6 | C4277682 | |
| Disease | Hepatitis, Drug-Induced | 2.83e-03 | 404 | 102 | 6 | C1262760 | |
| Disease | Hepatitis, Toxic | 2.83e-03 | 404 | 102 | 6 | C0019193 | |
| Disease | Chemically-Induced Liver Toxicity | 2.83e-03 | 404 | 102 | 6 | C4279912 | |
| Disease | non-high density lipoprotein cholesterol measurement | 3.34e-03 | 713 | 102 | 8 | EFO_0005689 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GTYGQVYKAKDKDTG | 736 | Q9NYV4 | |
| KEGGSRKDSGQYEKD | 1381 | Q6UB99 | |
| QVIGFSGLSDDKNYK | 26 | Q9UL15 | |
| FYGHKEKDKGLQTTQ | 56 | Q96L12 | |
| YGSGDEDGKSEKRKN | 556 | Q8TDI0 | |
| KNGYQSDAKGVKTFV | 636 | Q9UNA0 | |
| NEVYGKESYGKEKGD | 996 | Q86SQ4 | |
| EKGDVNGEKEQKFYT | 136 | P22352 | |
| EAFKQLLYDKNGEGT | 1061 | A6QL63 | |
| DGYIKNTEKLNYGKE | 216 | O94985 | |
| DKDQEDYFQKGGLQI | 441 | Q8IYM0 | |
| EGKNNGSVGKVQYFK | 321 | Q8N3C7 | |
| AKGKNDGSVGDKRYF | 661 | Q8N3C7 | |
| AINKGNKKVTEEDFY | 351 | P19835 | |
| KKNDYFKGLIEGSAQ | 341 | O95905 | |
| FYKKDNEFKEKGIGT | 366 | Q9UKX7 | |
| GQENYFGENDAEKVK | 996 | Q09MP3 | |
| LFQEKKEEGYGEAAQ | 501 | Q9ULC6 | |
| EQESKKAGKASFAYA | 296 | Q9Y450 | |
| AFGGQKKELERYNKN | 266 | P08183 | |
| EAGKDQGYYIREKSK | 111 | Q8IYW4 | |
| DFKGTGIKVYDDGQK | 201 | Q9NP74 | |
| KSDKTGKNYDFAQVL | 691 | Q504Q3 | |
| SNSEGYLFQLEKGKK | 621 | Q6NUN7 | |
| FKSKGNYDEGFGRKQ | 96 | Q9BT23 | |
| KQDGSEKYYVDSVKG | 71 | P01780 | |
| FPDGSKEEGKYKNNI | 321 | Q9HDC5 | |
| YKEEFEKNKGKGFSV | 86 | Q14847 | |
| GKKSHNKQFDNYGEE | 171 | Q92499 | |
| KYQKGFSDKLDFLEG | 201 | Q99848 | |
| QTDRYEFKVNAKDKG | 601 | O60245 | |
| KAKDQGFFVKNQEGE | 451 | Q8TET4 | |
| GGTEGLKKYYKELQN | 1126 | Q6ZR08 | |
| ELASGEYFLKANQKK | 281 | Q13601 | |
| NQKKGAYDIFLNAKE | 1046 | P42704 | |
| EDGSFIGQYSGKKEK | 1221 | P32004 | |
| QSKYGDFNKEVHKSG | 131 | P26038 | |
| QKTYNKEKLCDFTDG | 676 | Q9GZU2 | |
| YQDDELGKKQFKYGN | 21 | P33993 | |
| ADVSGKYFDGLKQKA | 281 | Q8NBN7 | |
| GIFSYDKAKDNVEKE | 26 | Q96MD2 | |
| EDGSFIGQYTVKKDK | 1311 | O94856 | |
| NEGQGFKIKYEAKSL | 2201 | O60494 | |
| NSIKDVEQKKSGNYF | 581 | P61221 | |
| GSKFGDLDEQEFVYK | 1801 | Q8NF50 | |
| AYNKDKESKPAQGQF | 101 | Q05707 | |
| FKVGDEKNFYELNIG | 191 | Q08830 | |
| LDYFSDKESGKQKFN | 381 | Q9NYF8 | |
| KRKQYDQFGDDKSQA | 166 | Q9NXW2 | |
| LKIKAYDADSGFNGK | 746 | Q8TDW7 | |
| LSSGKFYGDEEKDKG | 51 | P27797 | |
| FYGDEEKDKGLQTSQ | 56 | P27797 | |
| QLQGNKEYGSEKKGY | 316 | Q9ULH1 | |
| LAYEKQNFALGKGDE | 66 | Q8NEU8 | |
| FGEYKGDQQDKLLES | 466 | Q494V2 | |
| DGKLYAKTGDAVEFQ | 526 | Q9BXR6 | |
| KENNKKAYDGFASIG | 501 | Q8NDI1 | |
| LNADGTQKGIDKEFY | 566 | Q6MZM0 | |
| FGNEIYTVKFQKKGD | 336 | O43148 | |
| FCKKREENGEGYEKA | 871 | O15068 | |
| EDGNKAFKEGNYKLA | 261 | Q99615 | |
| LKDFQYVDRDGKDQG | 106 | Q9Y6I3 | |
| KQDGYVQFDKASKAS | 736 | Q8IZU9 | |
| QAKFGDYNKEVHKSG | 131 | P15311 | |
| KDNVSLKKGDFYQED | 436 | A6NE01 | |
| GYFEKGPIKASQNKD | 71 | Q92674 | |
| GKSIYGKKFDDENFI | 211 | Q9UNP9 | |
| NKDKEGKVFYSITGQ | 181 | P12830 | |
| QKAKAEEEGYFEAFK | 246 | Q7L3B6 | |
| FGYTKDKEQDLLQAG | 186 | Q9UNU6 | |
| KQIQEAYGKCKEFGD | 66 | Q9UNL4 | |
| YNAKDKTVGDFLKQQ | 1016 | Q9Y6K5 | |
| GNTVFVYNDKKGTED | 921 | A8MW92 | |
| GKKKSQIQEYVDYNG | 246 | P32754 | |
| GKDEDFKQYVNKNSK | 636 | P07814 | |
| NKKFQEKDYTGAAVL | 76 | Q8IYR2 | |
| GDGAFGKVYKAQNKE | 41 | Q9H2G2 | |
| GKNNDFSKLVAGEYL | 581 | A5PKW4 | |
| TVGFGDQINKDDSYK | 101 | Q9NVA2 | |
| NYDDDEKKVTGGRNG | 171 | Q02880 | |
| YFQNGGKRKALEKDE | 106 | Q1RMZ1 | |
| YYGSDKDKQQKGEFA | 151 | O75563 | |
| KDKQQKGEFAIDGYS | 156 | O75563 | |
| NPDGSEKKDFYKDGK | 411 | Q16647 | |
| GAEDFKQQVPYKEDK | 136 | O75182 | |
| QYLLTLGFKNKDDGK | 381 | Q9BXB7 | |
| FSGNKALLYKKNEDG | 286 | Q96AB6 | |
| FDFGKDIKDDNYSNK | 286 | O15091 | |
| KYGLEGTVFFEEKDK | 866 | Q9Y2L1 | |
| TETEIQKKANDKGFY | 211 | Q8TEV9 | |
| TGYFFFQEKEKELGK | 341 | Q7Z4H8 | |
| NIFGVESGKKEYSLD | 131 | Q9GZS3 | |
| IEKGSSYGNQEFKKK | 361 | Q9NRZ7 | |
| DKKNGKSYENKSGEN | 161 | Q7Z417 | |
| GFQVEYKDFPKNNKN | 501 | O95793 | |
| DVFKKGDQAYLTGDV | 476 | Q6P1M0 | |
| KDRGNGFFKEGKYER | 286 | Q9H6T3 | |
| GTNYLADVFEKKDKN | 51 | P31151 | |
| REKEKGNEAFNSGDY | 211 | Q07617 | |
| KADDKGSNKGFEATY | 71 | A0A087WT02 | |
| FESKVGNKYLNEAAG | 361 | Q8IZH2 | |
| LKKTETYEKENCGGF | 431 | Q8N841 | |
| KYDKKTGNFQVTELG | 971 | O75643 | |
| KSKIEGEKEQQEGYF | 126 | Q9HCL3 | |
| GKKSYEGKNFENIFT | 171 | Q86UD4 | |
| GDSIVGYKEKSKFQD | 331 | P16473 | |
| GQNGLEFYCKTKDLK | 476 | Q9UKW4 | |
| QKLNGFGAYEKKLDD | 111 | Q68DI1 | |
| VASEIFKGKKDNYPQ | 876 | O00159 | |
| VEESNKFYKDNIKAG | 116 | P22033 | |
| KFYKDNIKAGQQGLS | 121 | P22033 | |
| EDSGKYSINIKNKYG | 1411 | P54296 |